ROIV
Roivant Sciences Ltd. · Healthcare
President and CIO Mayukh Sukhatme sold $12.4M of Roivant Sciences Ltd.
Sold$12,360,813
$36.88Price
335,174Shares
−2%Stake
What ROIV did after the filing
- The stock from Mon, Aug 24 open, $36.22
- −1.9%
- S&P 500, same days
- +1.9%
Measured over 30 trading days, to the Oct 6 close.
Traded Wed, Aug 19. Filed Fri, Aug 21, 9:00 PM ET, after the close. Returns use the Aug 24 open and the Oct 6 close. Not investment advice.